Skip to main content
Figure 6 | Cardiovascular Diabetology

Figure 6

From: Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Figure 6

Percentage of time with glucose level ≥180 mg/dl, ≥70 to <180 mg/dl, and <70 mg/dl, based on analyses of covariance in the full analysis set. Baseline data are means, day 1 and day 28 data are adjusted means. **p<0.01; ***p<0.001 for difference vs placebo in change from baseline; †n=20 at day 28.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840